Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-089483
Filing Date
2015-03-12
Accepted
2015-03-12 17:29:05
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d843164d10k.htm 10-K 727186
2 EX-23.1 d843164dex231.htm EX-23.1 2428
3 EX-31.1 d843164dex311.htm EX-31.1 6675
4 EX-31.2 d843164dex312.htm EX-31.2 6669
5 EX-32.1 d843164dex321.htm EX-32.1 3839
6 EX-32.2 d843164dex322.htm EX-32.2 4154
  Complete submission text file 0001193125-15-089483.txt   5253885

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnov-20141231.xml EX-101.INS 516344
8 XBRL TAXONOMY EXTENSION SCHEMA mnov-20141231.xsd EX-101.SCH 50279
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20141231_cal.xml EX-101.CAL 65922
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20141231_def.xml EX-101.DEF 305193
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20141231_lab.xml EX-101.LAB 426508
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20141231_pre.xml EX-101.PRE 358345
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 15696932
SIC: 2834 Pharmaceutical Preparations